SH2D1A Protein (Transcript Variant 1) (Myc-DYKDDDDK Tag)
Quick Overview for SH2D1A Protein (Transcript Variant 1) (Myc-DYKDDDDK Tag) (ABIN2731954)
Target
See all SH2D1A ProteinsProtein Type
Origin
Source
Application
Purity
-
-
Protein Characteristics
- Transcript Variant 1
-
Purification tag / Conjugate
- This SH2D1A protein is labelled with Myc-DYKDDDDK Tag.
-
Characteristics
-
- Recombinant human SH2D1A (transcript variant 1) protein expressed in HEK293 cells.
- Produced with end-sequenced ORF clone
-
-
Want other Options for this Protein ?
!Discover Our Predefined Custom Proteins and Custom Protein Services!ProductExpression SystemConjugateOriginPrice starts atExpression System Cell-free protein synthesis (CFPS)Conjugate Strep TagOrigin HumanPrice starts at $19,692.86Your project requires further customization? Contact us and discover our custom protein solutions
-
-
-
Application Notes
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays -
Comment
-
The tag is located at the C-terminal.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 50 μg/mL
-
Buffer
- 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
-
Storage
- -80 °C
-
Storage Comment
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
-
- SH2D1A (SH2 Domain Containing 1A (SH2D1A))
-
Alternative Name
- Sh2d1a
-
Background
- This gene encodes a protein that plays a major role in the bidirectional stimulation of T and B cells. This protein contains an SH2 domain and a short tail. It associates with the signaling lymphocyte-activation molecule, thereby acting as an inhibitor of this transmembrane protein by blocking the recruitment of the SH2-domain-containing signal-transduction molecule SHP-2 to its docking site. This protein can also bind to other related surface molecules that are expressed on activated T, B and NK cells, thereby modifying signal transduction pathways in these cells. Mutations in this gene cause lymphoproliferative syndrome X-linked type 1 or Duncan disease, a rare immunodeficiency characterized by extreme susceptibility to infection with Epstein-Barr virus, with symptoms including severe mononucleosis and malignant lymphoma. Multiple transcript variants encoding different isoforms have been found for this gene.
-
Molecular Weight
- 14 kDa
-
NCBI Accession
- NP_002342
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
Target
-